Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Maria Masucci

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Human Herpesvirus 4

Chemicals & Drugs

Anatomy

Disorders

Burkitt Lymphoma

Physiology

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
31
LEVITSKY, VICTOR
29
Klein, George
16
Frisan, Teresa
15
Dantuma, Nico
14
Gavioli, Riccardo
14
Masucci, Giuseppe
11
Klein, Eva
10
Lindsten, Kristina
8
Bejarano, Maria Teresa
8
Sharipo, Anatoly
7
Trivedi, Pankaj
6
Rickinson, Alan
6
Dolcetti, Riccardo
6
Leonchiks, Ainars
6
Levitskaya, Jelena

Sign-in to see all Coauthors

Publications

TOP 3
Gruhne B; Sompallae R; Masucci M G
Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints.
Preta G; Marescotti D; Fortini C; Carcoforo P; Castelli C; Masucci M; Gavioli R
Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.
Sompallae Ramakrishna; Gastaldello Stefano; Hildebrand Sebastian; Zinin Nikolay; Hassink Gerco; Lindsten Kristina; Haas Juergen; Persson Bengt; Masucci Maria G
Epstein-barr virus encodes three bona fide ubiquitin-specific proteases.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Maria Masucci (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Gruhne B; Sompallae R; Masucci M G
Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints.
Oncogene 2009;28(45):3997-4008.
2008: Preta G; Marescotti D; Fortini C; Carcoforo P; Castelli C; Masucci M; Gavioli R
Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.
Scandinavian journal of immunology 2008;68(6):579-88.
2008: Sompallae Ramakrishna; Gastaldello Stefano; Hildebrand Sebastian; Zinin Nikolay; Hassink Gerco; Lindsten Kristina; Haas Juergen; Persson Bengt; Masucci Maria G
Epstein-barr virus encodes three bona fide ubiquitin-specific proteases.
Journal of virology 2008;82(21):10477-86.
2008: Guerra Lina; Carr Heather S; Richter-Dahlfors Agneta; Masucci Maria G; Thelestam Monica; Frost Jeffrey A; Frisan Teresa
A bacterial cytotoxin identifies the RhoA exchange factor Net1 as a key effector in the response to DNA damage.
PloS one 2008;3(5):e2254.
2007: Li Jiang; Zhang Xiao-Shi; Xie Dan; Deng Hai-Xia; Gao Yan-Fang; Chen Qiu-Yan; Huang Wen-Lin; Masucci Maria G; Zeng Yi-xin
Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
Cancer biology & therapy 2007;6(12):1997-2004.
2007: Liu Ji-Yan; Wu Yang; Zhang Xiao-Shi; Yang Jin-Liang; Li Hong-Li; Mao Yong-Qiu; Wang Yi; Cheng Xia; Li Yong-Qiang; Xia Jian-Chuan; Masucci Maria; Zeng Yi-Xin
Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine.
Cancer immunology, immunotherapy : CII 2007;56(10):1597-604.
2007: Kamranvar S A; Gruhne B; Szeles A; Masucci M G
Epstein-Barr virus promotes genomic instability in Burkitt's lymphoma.
Oncogene 2007;26(35):5115-23.
2007: Li Jiang; Zeng Xue-hui; Mo Hao-yuan; Rolén Ulrika; Gao Yan-fang; Zhang Xiao-shi; Chen Qiu-yan; Zhang Li; Zeng Mu-sheng; Li Man-zhi; Huang Wen-lin; Wang Xiao-ning; Zeng Yi-xin; Masucci Maria G
Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy.
PloS one 2007;2(11):e1122.
2006: Uhlin M; Masucci M; Levitsky V
Is the activity of partially agonistic MHC:peptide ligands dependent on the quality of immunological help?
Scandinavian journal of immunology 2006;64(6):581-7.
2006: Stavropoulou Vaia; Vasquez Vanessa; Cereser Biancastella; Freda Elio; Masucci Maria G
TPPII promotes genetic instability by allowing the escape from apoptosis of cells with activated mitotic checkpoints.
Biochemical and biophysical research communications 2006;346(2):415-25.
2006: Lindsten Kristina; Menéndez-Benito Victoria; Masucci Maria G; Dantuma Nico P; Kumarapeli Asangi R K; Horak Kathleen M; Zheng Hanqiao; Wang Xuejun
GFP reporter mouse models of UPS proteolytic function.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(7):1027; author reply 1027-8.
2006: Majerová-Uhlíková Tat'ána; Dantuma Nico P; Lindsten Kristina; Masucci Maria G; Konvalinka Jan
Non-infectious fluorimetric assay for phenotyping of drug-resistant HIV proteinase mutants.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;36(1):50-9.
2006: Rolén Ulrika; Kobzeva Vera; Gasparjan Natalja; Ovaa Huib; Winberg Gösta; Kisseljov Fjodor; Masucci Maria G
Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines.
Molecular carcinogenesis 2006;45(4):260-9.
2006: Bosch-Comas A; Lindsten K; Gonzàlez-Duarte R; Masucci M G; Marfany G
The ubiquitin-specific protease USP25 interacts with three sarcomeric proteins.
Cellular and molecular life sciences : CMLS 2006;63(6):723-34.
2005: Uhlin Michael; Sandalova Elena; Masucci Maria Gracia; Levitsky Victor
Help signals provided by lymphokines modulate the activation and apoptotic programs induced by partially agonistic peptides in specific cytotoxic T lymphocytes.
European journal of immunology 2005;35(10):2929-39.
2005: Menéndez-Benito Victoria; Verhoef Lisette G G C; Masucci Maria G; Dantuma Nico P
Endoplasmic reticulum stress compromises the ubiquitin-proteasome system.
Human molecular genetics 2005;14(19):2787-99.
2005: Uhlin Michael; Masucci Maria G; Levitsky Victor
Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(26):9264-9.
2005: Heessen Stijn; Masucci Maria G; Dantuma Nico P
The UBA2 domain functions as an intrinsic stabilization signal that protects Rad23 from proteasomal degradation.
Molecular cell 2005;18(2):225-35.
2005: Stavropoulou Vaia; Xie Jianjun; Henriksson Marie; Tomkinson Birgitta; Imreh Stefan; Masucci Maria G
Mitotic infidelity and centrosome duplication errors in cells overexpressing tripeptidyl-peptidase II.
Cancer research 2005;65(4):1361-8.
2005: Sundström Sara; Ota Seisuke; Dimberg Lina Y; Masucci Maria G; Bergqvist Anders
Hepatitis C virus core protein induces an anergic state characterized by decreased interleukin-2 production and perturbation of mitogen-activated protein kinase responses.
Journal of virology 2005;79(4):2230-9.
2004: Cartier A; Masucci M G
Differential regulation of MHC class-I-restricted and unrestricted cytotoxicity by the Us3 protein kinase of herpes simplex virus-1.
Scandinavian journal of immunology 2004;60(6):592-9.
2004: Issaeva Natalia; Bozko Przemyslaw; Enge Martin; Protopopova Marina; Verhoef Lisette G G C; Masucci Maria; Pramanik Aladdin; Selivanova Galina
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors.
Nature medicine 2004;10(12):1321-8.
2004: Guerreiro-Cacais Andre Ortlieb; Li LiQi; Donati Daria; Bejarano Maria Teresa; Morgan Andrew; Masucci Maria G; Hutt-Fletcher Lindsey; Levitsky Victor
Capacity of Epstein-Barr virus to infect monocytes and inhibit their development into dendritic cells is affected by the cell type supporting virus replication.
The Journal of general virology 2004;85(Pt 10):2767-78.
2004: Liu Daorong; Tammik Charlotte; Zou Jie-Zhi; Ernberg Ingemar; Masucci Maria G; Ringden Olle; Levitsky Victor
Effect of combined T- and B-cell depletion of allogeneic HLA-mismatched bone marrow graft on the magnitude and kinetics of Epstein-Barr virus load in the peripheral blood of bone marrow transplant recipients.
Clinical transplantation 2004;18(5):518-24.
2004: Masucci Maria G
Epstein-Barr virus oncogenesis and the ubiquitin-proteasome system.
Oncogene 2004;23(11):2107-15.
2004: Sandalova Elena; Wei Cheng-Hong; Masucci Maria G; Levitsky Victor
Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(9):3011-6.
2004: Ovaa Huib; Kessler Benedikt M; Rolén Ulrika; Galardy Paul J; Ploegh Hidde L; Masucci Maria G
Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(8):2253-8.
2003: Heessen Stijn; Dantuma Nico P; Tessarz Peter; Jellne Marianne; Masucci Maria G
Inhibition of ubiquitin/proteasome-dependent proteolysis in Saccharomyces cerevisiae by a Gly-Ala repeat.
FEBS letters 2003;555(2):397-404.
2003: Cartier A; Broberg E; Komai T; Henriksson M; Masucci M G
The herpes simplex virus-1 Us3 protein kinase blocks CD8T cell lysis by preventing the cleavage of Bid by granzyme B.
Cell death and differentiation 2003;10(12):1320-8.
2003: Cartier Anna; Komai Tomoaki; Masucci Maria G
The Us3 protein kinase of herpes simplex virus 1 blocks apoptosis and induces phosporylation of the Bcl-2 family member Bad.
Experimental cell research 2003;291(1):242-50.
2003: Lindsten Kristina; Menéndez-Benito Victoria; Masucci Maria G; Dantuma Nico P
A transgenic mouse model of the ubiquitin/proteasome system.
Nature biotechnology 2003;21(8):897-902.
2003: Dolcetti Riccardo; Masucci Maria G
Epstein-Barr virus: induction and control of cell transformation.
Journal of cellular physiology 2003;196(2):207-18.
2003: Bergqvist Anders; Sundström Sara; Dimberg Lina Y; Gylfe Erik; Masucci Maria G
The hepatitis C virus core protein modulates T cell responses by inducing spontaneous and altering T-cell receptor-triggered Ca2+ oscillations.
The Journal of biological chemistry 2003;278(21):18877-83.
2003: Sabri Farideh; Chiodi Francesca; Piret Jean-Pascal; Wei Cheng-Hong; Major Eugene; Westermark Bengt; Masucci Maria G; Levitsky Victor
Soluble factors released by virus specific activated cytotoxic T-lymphocytes induce apoptotic death of astroglioma cell lines.
Brain pathology (Zurich, Switzerland) 2003;13(2):165-75.
2003: Uhlin M; Masucci M G; Levitsky V
Pharmacological disintegration of lipid rafts decreases specific tetramer binding and disrupts the CD3 complex and CD8 heterodimer in human cytotoxic T lymphocytes.
Scandinavian journal of immunology 2003;57(2):99-106.
2003: Dantuma Nico P; Masucci Maria G
The ubiquitin/proteasome system in Epstein-Barr virus latency and associated malignancies.
Seminars in cancer biology 2003;13(1):69-76.
2002: Verhoef Lisette G G C; Lindsten Kristina; Masucci Maria G; Dantuma Nico P
Aggregate formation inhibits proteasomal degradation of polyglutamine proteins.
Human molecular genetics 2002;11(22):2689-700.
2002: Wei Cheng-Hong; Uhlin Michael; Masucci Maria G; Levitsky Victor
Tetramer binding and secretion of interferon-gamma in response to antigenic stimulation are compatible with a range of affinities of MHC:TCR interaction and distinct programs of cytotoxic T-lymphocyte activation.
Human immunology 2002;63(10):821-33.
2002: Dantuma Nico P; Masucci Maria G
Stabilization signals: a novel regulatory mechanism in the ubiquitin/proteasome system.
FEBS letters 2002;529(1):22-6.
2002: Gavioli Riccardo; Vertuani Simona; Masucci Maria G
Proteasome inhibitors reconstitute the presentation of cytotoxic T-cell epitopes in Epstein-Barr virus-associated tumors.
International journal of cancer. Journal international du cancer 2002;101(6):532-8.
2002: Levitsky Victor; Masucci Maria G
Manipulation of immune responses by Epstein-Barr virus.
Virus research 2002;88(1-2):71-86.
2002: Leonchiks Ainars; Stavropoulou Vaya; Sharipo Anatoly; Masucci Maria G
Inhibition of ubiquitin-dependent proteolysis by a synthetic glycine-alanine repeat peptide that mimics an inhibitory viral sequence.
FEBS letters 2002;522(1-3):93-8.
2002: Li LiQi; Liu Daorong; Hutt-Fletcher Lindsey; Morgan Andrew; Masucci Maria G; Levitsky Victor
Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage-colony-stimulating factor and interleukin-4.
Blood 2002;99(10):3725-34.
2002: Lindsten Kristina; de Vrij Femke M S; Verhoef Lisette G G C; Fischer David F; van Leeuwen Fred W; Hol Elly M; Masucci Maria G; Dantuma Nico P
Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation.
The Journal of cell biology 2002;157(3):417-27.
2002: Staege Martin S; Lee Steven P; Frisan Teresa; Mautner Josef; Scholz Siegfried; Pajic Alexander; Rickinson Alan B; Masucci Maria G; Polack Axel; Bornkamm Georg W
MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(7):4550-5.
2002: Li LiQi; Sharipo Anatoly; Chaves-Olarte Esteban; Masucci Maria G; Levitsky Victor; Thelestam Monica; Frisan Teresa
The Haemophilus ducreyi cytolethal distending toxin activates sensors of DNA damage and repair complexes in proliferating and non-proliferating cells.
Cellular microbiology 2002;4(2):87-99.
2002: Heessen Stijn; Leonchiks Ainars; Issaeva Natalia; Sharipo Anatoly; Selivanova Galina; Masucci Maria G; Dantuma Nico P
Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(3):1532-7.
2002: Dantuma N P; Sharipo A; Masucci M G
Avoiding proteasomal processing: the case of EBNA1.
Current topics in microbiology and immunology 2002;269():23-36.
2001: Lindsten K; Uhlíková T; Konvalinka J; Masucci M G; Dantuma N P
Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activity.
Antimicrobial agents and chemotherapy 2001;45(9):2616-22.
2001: Sharipo A; Imreh M; Leonchiks A; Brändén C; Masucci M G
cis-Inhibition of proteasomal degradation by viral repeats: impact of length and amino acid composition.
FEBS letters 2001;499(1-2):137-42.
2001: Gavioli R; Frisan T; Vertuani S; Bornkamm G W; Masucci M G
c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells.
Nature cell biology 2001;3(3):283-8.
2001: Wei C H; Yagita H; Masucci M G; Levitsky V
Different programs of activation-induced cell death are triggered in mature activated CTL by immunogenic and partially agonistic peptide ligands.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(2):989-95.
2001: Frisan T; Levitsky V; Masucci M
Limiting dilution assay.
Methods in molecular biology (Clifton, N.J.) 2001;174():213-6.
2001: Levitsky V; Frisan T; Masucci M
Determination of antigen and fine peptide specificity of EBV-specific CTLs.
Methods in molecular biology (Clifton, N.J.) 2001;174():209-11.
2001: Levitsky V; Frisan T; Masucci M
Generation of polyclonal EBV-specific CTL cultures and clones.
Methods in molecular biology (Clifton, N.J.) 2001;174():203-8.
2001: Frisan T; Levitsky V; Masucci M
Regression assay.
Methods in molecular biology (Clifton, N.J.) 2001;174():199-201.
2001: Frisan T; Levitsky V; Masucci M
Generation of lymphoblastoid cell lines (LCLs).
Methods in molecular biology (Clifton, N.J.) 2001;174():125-7.
2000: Frisan T; Levitsky V; Masucci M G
Variations in proteasome subunit composition and enzymatic activity in B-lymphoma lines and normal B cells.
International journal of cancer. Journal international du cancer 2000;88(6):881-8.
2000: Levitsky V; Liu D; Southwood S; Levitskaya J; Sette A; Masucci M G
Supermotif peptide binding and degeneracy of MHC: peptide recognition in an EBV peptide-specific CTL response with highly restricted TCR usage.
Human immunology 2000;61(10):972-84.
2000: Aviel S; Winberg G; Massucci M; Ciechanover A
Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue.
The Journal of biological chemistry 2000;275(31):23491-9.
2000: Dantuma N P; Heessen S; Lindsten K; Jellne M; Masucci M G
Inhibition of proteasomal degradation by the gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(15):8381-5.
2000: Dantuma N P; Lindsten K; Glas R; Jellne M; Masucci M G
Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells.
Nature biotechnology 2000;18(5):538-43.
2000: Li L; Masucci M G; Levitsky V
Effect of interleukin-7 on the in vitro development and maturation of monocyte derived human dendritic cells.
Scandinavian journal of immunology 2000;51(4):361-71.
2000: Gustafsson A; Levitsky V; Zou J Z; Frisan T; Dalianis T; Ljungman P; Ringden O; Winiarski J; Ernberg I; Masucci M G
Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells.
Blood 2000;95(3):807-14.
1999: Frisan T; Donati D; Cervenak L; Wilson J; Masucci M G; Bejarano M T
CD40 cross-linking enhances the immunogenicity of Burkitt's-lymphoma cell lines.
International journal of cancer. Journal international du cancer 1999;83(6):772-9.
1999: Wei C H; Beeson C; Masucci M G; Levitsky V
A partially agonistic peptide acts as a selective inducer of apoptosis in CD8+ CTLs.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(5):2601-9.
1999: Reali E; Guerrini R; Marastoni M; Tomatis R; Masucci M G; Traniello S; Gavioli R
A single specific amino acid residue in peptide antigens is sufficient to activate memory CTL: potential role of cross-reactive peptides in memory T cell maintenance.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(1):106-13.
1998: Leonchiks A; Liepinsh E; Barishev M; Sharipo A; Masucci M G; Otting G
Random coil conformation of a Gly/Ala-rich insert in IkappaB alpha excludes structural stabilization as the mechanism for protection against proteasomal degradation.
FEBS letters 1998;440(3):365-9.
1998: Bejarano M T; Masucci M G
Interleukin-10 abrogates the inhibition of Epstein-Barr virus-induced B-cell transformation by memory T-cell responses.
Blood 1998;92(11):4256-62.
1998: Sharipo A; Imreh M; Leonchiks A; Imreh S; Masucci M G
A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: a new mechanism for selective inhibition of proteolysis.
Nature medicine 1998;4(8):939-44.
1998: Levitsky V; de Campos-Lima P O; Frisan T; Masucci M G
The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(2):594-601.
1998: Frisan T; Levitsky V; Polack A; Masucci M G
Phenotype-dependent differences in proteasome subunit composition and cleavage specificity in B cell lines.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(7):3281-9.
1998: Gavioli R; Guerrini R; Masucci M G; Tomatis R; Traniello S; Marastoni M
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes.
FEBS letters 1998;421(2):95-9.
1997: Levitsky V; Zhang Q J; Levitskaya J; Kurilla M G; Masucci M G
Natural variants of the immunodominant HLA A11-restricted CTL epitope of the EBV nuclear antigen-4 are nonimmunogenic due to intracellular dissociation from MHC class I:peptide complexes.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(11):5383-90.
1997: Levitskaya J; Sharipo A; Leonchiks A; Ciechanover A; Masucci M G
Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(23):12616-21.
1997: Campos-Lima P O; Levitsky V; Imreh M P; Gavioli R; Masucci M G
Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr virus.
The Journal of experimental medicine 1997;186(1):83-9.
1996: Frisan T; Zhang Q J; Levitskaya J; Coram M; Kurilla M G; Masucci M G
Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells.
International journal of cancer. Journal international du cancer 1996;68(2):251-8.
1996: Gavioli R; Zhang Q J; Masucci M G
HLA-A11-mediated protection from NK cell-mediated lysis: role of HLA-A11-presented peptides.
Human immunology 1996;49(1):1-12.
1996: Reali E; Guerrini R; Giori B; Borghi M; Marastoni M; Tomatis R; Traniello S; Masucci M G; Gavioli R
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides.
Clinical and experimental immunology 1996;105(2):369-75.
1996: Zhang Q J; Lindquist Y; Levitsky V; Masucci M G
Solvent exposed side chains of peptides bound to HLA A*1101 have similar effects on the reactivity of alloantibodies and specific TCR.
International immunology 1996;8(6):927-38.
1996: Levitsky V; Zhang Q J; Levitskaya J; Masucci M G
The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4.
The Journal of experimental medicine 1996;183(3):915-26.
1995: Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima P O; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci M G; Boiocchi M
Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Cancer research 1995;55(16):3675-81.
1995: Imreh M P; Zhang Q J; de Campos-Lima P O; Imreh S; Krausa P; Browning M; Klein G; Masucci M G
Mechanisms of allele-selective down-regulation of HLA class I in Burkitt's lymphoma.
International journal of cancer. Journal international du cancer 1995;62(1):90-6.
1995: Levitskaya J; Coram M; Levitsky V; Imreh S; Steigerwald-Mullen P M; Klein G; Kurilla M G; Masucci M G
Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.
Nature 1995;375(6533):685-8.
1995: Gavioli R; Zhang Q J; Marastoni M; Guerrini R; Reali E; Tomatis R; Masucci M G; Traniello S
Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes.
Biochemical and biophysical research communications 1995;206(1):8-14.
1994: Matsuda M; Salazar F; Petersson M; Masucci G; Hansson J; Pisa P; Zhang Q J; Masucci M G; Kiessling R
Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.
The Journal of experimental medicine 1994;180(6):2371-6.
1994: Nakagomi H; Dolcetti R; Bejarano M T; Pisa P; Kiessling R; Masucci M G
The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines.
International journal of cancer. Journal international du cancer 1994;57(2):240-4.
1994: Masucci M G; Ernberg I
Epstein-Barr virus: adaptation to a life within the immune system.
Trends in microbiology 1994;2(4):125-30.
1994: de Campos-Lima P O; Levitsky V; Brooks J; Lee S P; Hu L F; Rickinson A B; Masucci M G
T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues.
The Journal of experimental medicine 1994;179(4):1297-305.
1994: Trivedi P; Hu L F; Chen F; Christensson B; Masucci M G; Klein G; Winberg G
Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue.
European journal of cancer (Oxford, England : 1990) 1994;30A(1):84-8.
1993: Masucci M G
Viral immunopathology of human tumors.
Current opinion in immunology 1993;5(5):693-700.
1993: Masucci M G; Gavioli R; de Campos-Lima P O; Zhang Q J; Trivedi P; Dolcetti R
Transformation-associated Epstein-Barr virus antigens as targets for immune attack.
Annals of the New York Academy of Sciences 1993;690():86-100.
1993: Trivedi P; Cuomo L; de Campos-Lima P O; Imreh M P; Kvarnung K; Klein G; Masucci M G
Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
The Journal of general virology 1993;74 ( Pt 7)():1393-8.
1993: Cuomo L; Zhang Q J; Lombardi L; Torsteinsdottir S; Klein G; Dalla-Favera R; Masucci M G
Over-expression of C-myc increases the sensitivity of Epstein-Barr virus immortalized lymphoblastoid cells to non-MHC-restricted cytotoxicity.
International journal of cancer. Journal international du cancer 1993;53(6):1008-12.
1993: Nilsson T; Sjöblom A; Masucci M G; Rymo L
Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
Virology 1993;193(2):774-85.
1993: de Campos-Lima P O; Gavioli R; Zhang Q J; Wallace L E; Dolcetti R; Rowe M; Rickinson A B; Masucci M G
HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population.
Science (New York, N.Y.) 1993;260(5104):98-100.
1993: Cuomo L; Trivedi P; de Campos-Lima P O; Zhang Q J; Ragnar E; Klein G; Masucci M G
Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines.
Molecular immunology 1993;30(5):441-50.
1993: Zhang Q J; Gavioli R; Klein G; Masucci M G
An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(6):2217-21.
1993: de Campos-Lima P O; Torsteinsdóttir S; Cuomo L; Klein G; Sulitzeanu D; Masucci M G
Antigen processing and presentation by EBV-carrying cell lines: cell-phenotype dependence and influence of the EBV-encoded LMP1.
International journal of cancer. Journal international du cancer 1993;53(5):856-62.
1993: Gavioli R; Kurilla M G; de Campos-Lima P O; Wallace L E; Dolcetti R; Murray R J; Rickinson A B; Masucci M G
Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4.
Journal of virology 1993;67(3):1572-8.
1992: Larsson L G; Oberg F; Stöckbauer P; Masucci M G; Nilsson K
Suppression of basal, PMA- and IFN-alpha-, but not IFN-gamma-induced expression of HLA class I in v-myc-transformed U-937 monoblasts.
International journal of cancer. Journal international du cancer 1992;52(5):759-65.
1992: Masucci M G; Zhang Q J; Gavioli R; De Campos-Lima P O; Murray R J; Brooks J; Griffin H; Ploegh H; Rickinson A B
Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
International immunology 1992;4(11):1283-92.
1992: Cuomo L; Ramquist T; Trivedi P; Wang F; Klein G; Masucci M G
Expression of the Epstein-Barr virus (EBV)-encoded membrane protein LMP1 impairs the in vitro growth, clonability and tumorigenicity of an EBV-negative Burkitt lymphoma line.
International journal of cancer. Journal international du cancer 1992;51(6):949-55.
1992: Gavioli R; De Campos-Lima P O; Kurilla M G; Kieff E; Klein G; Masucci M G
Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(13):5862-6.
1992: Niedobitek G; Herbst H; Young L S; Brooks L; Masucci M G; Crocker J; Rickinson A B; Stein H
Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue.
Blood 1992;79(10):2520-6.
1992: Jansson A; Masucci M; Rymo L
Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines.
Journal of virology 1992;66(1):62-9.
1992: Rickinson A B; Murray R J; Brooks J; Griffin H; Moss D J; Masucci M G
T cell recognition of Epstein-Barr virus associated lymphomas.
Cancer surveys 1992;13():53-80.
1991: Contreras-Brodin B A; Anvret M; Imreh S; Altiok E; Klein G; Masucci M G
B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids.
The Journal of general virology 1991;72 ( Pt 12)():3025-33.
1991: Torsteinsdottir S; Cuomo L; Klein E; Masucci M G
Stimulation with allogeneic Epstein-Barr virus-transformed lymphoblastoid cell lines generates HLA class I-specific CTLs with different target cell avidity.
Cellular immunology 1991;137(2):501-13.
1991: Trivedi P; Masucci M G; Winberg G; Klein G
The epstein-Barr-virus-encoded membrane protein LMP but not the nuclear antigen EBNA-1 induces rejection of transfected murine mammary carcinoma cells.
International journal of cancer. Journal international du cancer 1991;48(5):794-800.
1991: Andersson M L; Stam N J; Klein G; Ploegh H L; Masucci M G
Aberrant expression of HLA class-I antigens in Burkitt lymphoma cells.
International journal of cancer. Journal international du cancer 1991;47(4):544-50.
1991: Masucci M G; Klein E
Cell phenotype dependent expression of MHC class I antigens in Burkitt's lymphoma cell lines.
Seminars in cancer biology 1991;2(1):63-71.
1991: Osterborg A; Masucci M; Bergenbrant S; Holm G; Lefvert A K; Mellstedt H
Generation of T cell clones binding F(ab')2 fragments of the idiotypic immunoglobulin in patients with monoclonal gammopathy.
Cancer immunology, immunotherapy : CII 1991;34(3):157-62.
1991: Avila-Cariño J; Torsteinsdottir S; Ehlin-Henriksson B; Masucci M G; Klein E
Search for the critical characteristics of phenotypically different B cell lines, Burkitt lymphoma cells and lymphoblastoid cell lines, which determine differences in their functional interaction with allogeneic lymphocytes.
Cancer immunology, immunotherapy : CII 1991;34(2):128-32.
1990: Contreras-Salazar B; Ehlin-Henriksson B; Klein G; Masucci M G
Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection.
Journal of virology 1990;64(11):5441-7.
1990: Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci M G
Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
European journal of immunology 1990;20(10):2293-9.
1990: Bejarano M T; Masucci M G; Morgan A; Morein B; Klein G; Klein E
Epstein-Barr virus (EBV) antigens processed and presented by B cells, B blasts, and macrophages trigger T-cell-mediated inhibition of EBV-induced B-cell transformation.
Journal of virology 1990;64(3):1398-401.
1990: Ljunggren H G; Oudshoorn-Snoek M; Masucci M G; Ploegh H L
High-resolution one-dimensional isoelectric focusing of mouse MHC class I antigens. Identification of natural and experimentally induced class I antigens.
Immunogenetics 1990;32(6):440-50.
1990: Masucci M G
Cell phenotype dependent down-regulation of MHC class I antigens in Burkitt's lymphoma cells.
Current topics in microbiology and immunology 1990;166():309-16.
1989: Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci M G; Klein G
The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
The Journal of general virology 1989;70 ( Pt 11)():2989-3002.
1989: Masucci M G; Contreras-Salazar B; Ragnar E; Falk K; Minarovits J; Ernberg I; Klein G
5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael.
Journal of virology 1989;63(7):3135-41.
1989: Masucci G; Mellstedt H; Henle G; Henle W; Rymo L; Masucci M G; Ernberg I; Klein G
Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients.
International journal of cancer. Journal international du cancer 1989;43(6):1017-21.
1989: Contreras-Salazar B; Klein G; Masucci M G
Host cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids.
Journal of virology 1989;63(6):2768-72.
1989: Masucci M G; Stam N J; Torsteinsdottir S; Neefjes J J; Klein G; Ploegh H L
Allele-specific down-regulation of MHC class I antigens in Burkitt lymphoma lines.
Cellular immunology 1989;120(2):396-400.
1989: Torsteinsdóttir S; Andersson M L; Avila-Cariño J; Ehlin-Henriksson B; Masucci M G; Klein G; Klein E
Reversion of tumorigenicity and decreased agarose clonability after EBV conversion of an IgH/myc translocation-carrying BL line.
International journal of cancer. Journal international du cancer 1989;43(2):273-8.
1988: Avila-Carino J; Torsteinsdottir S; Bejarano M T; Klein G; Klein E; Masucci M G
Combined treatment with interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha up-regulates the expression of HLA class I determinants in Burkitt lymphoma lines.
Cellular immunology 1988;117(2):303-11.
1988: Patel G V; Masucci M G; Winberg G; Klein G
Expression of the Epstein-Barr virus encoded EBNA-1 gene in stably transfected human and murine cell lines.
International journal of cancer. Journal international du cancer 1988;42(4):592-8.
1988: Bejarano M T; Masucci M G; Klein G; Klein E
T-cell-mediated inhibition of EBV-induced B-cell transformation: recognition of virus particles.
International journal of cancer. Journal international du cancer 1988;42(3):359-64.
1988: Torsteinsdottir S; Brautbar C; Klein G; Klein E; Masucci M G
Differential expression of HLA antigens on human B-cell lines of normal and malignant origin: a consequence of immune surveillance or a phenotypic vestige of the progenitor cells?
International journal of cancer. Journal international du cancer 1988;41(6):913-9.
1987: Avila-Cariño J; Torsteinsdottir S; Ehlin-Henriksson B; Lenoir G; Klein G; Klein E; Masucci M G
Paired Epstein-Barr virus (EBV)-negative and EBV-converted Burkitt lymphoma lines: stimulatory capacity in allogeneic mixed lymphocyte cultures.
International journal of cancer. Journal international du cancer 1987;40(5):691-7.
1987: Hatzubai A; Anafi M; Masucci M G; Dillner J; Lerner R A; Klein G; Sulitzeanu D
Down-regulation of the EBV-encoded membrane protein (LMP) in Burkitt lymphomas.
International journal of cancer. Journal international du cancer 1987;40(3):358-64.
1987: Bejarano M T; Thorsteinsdottir S; Andersson J P; Andersson U G; Masucci M G; Szigeti R; Klein E; Klein G
Defective cell-mediated response to EBV-transformed B cells in a healthy individual with regular EBV antibody titers.
International journal of cancer. Journal international du cancer 1987;40(2):149-56.
1987: Masucci M G; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G
Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(13):4567-71.
1987: Masucci M G; Szigeti R; Ernberg I; Hu C P; Torsteinsdottir S; Frade R; Klein E
Activation of B lymphocytes by Epstein-Barr virus/CR2 receptor interaction.
European journal of immunology 1987;17(6):815-20.
1987: Masucci G; Mellstedt H; Masucci M G; Ernberg I; Szigeti R; Henle G; Henle W; Klein G
Analysis of Epstein-Barr virus-specific and non-specific immune functions in a patient during the development of a non-Hodgkin's lymphoma.
European journal of cancer & clinical oncology 1987;23(4):379-86.
1987: Lewin N; Aman P; Masucci M G; Klein E; Klein G; Oberg B; Strander H; Henle W; Henle G
Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth.
International journal of cancer. Journal international du cancer 1987;39(4):472-6.
1987: Klein E; Torsteinsdottir S; Masucci M G
Allo-restricted cytotoxicity recognizing EBV-determined antigens. Comments.
The Journal of molecular and cellular immunology : JMCI 1987;3(3):195-7.
1986: Bejarano M T; Masucci M G; Klein E
Differential effect of cyclosporin-A on the mixed-lymphocyte culture-induced proliferative and cytotoxic responses of T lymphocytes with different cell densities.
Cellular immunology 1986;103(2):409-16.
1986: Torsteinsdottir S; Masucci M G; Ehlin-Henriksson B; Brautbar C; Ben Bassat H; Klein G; Klein E
Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(15):5620-4.
1986: Hu C P; Aman P; Masucci M G; Klein E; Klein G
B cell activation by the nontransforming P3HR-1 substrain of the Epstein-Barr virus (EBV).
European journal of immunology 1986;16(7):841-5.
1986: Klein E; Torsteinsdottir S; Masucci M G; Klein G
Different sensitivity of B cell lines derived from Burkitt lymphoma (BL) and normal cells (LCL) to cytotoxic T cell clones generated by autologous and allogeneic stimulation.
Journal of immunogenetics 1986;13(2-3):269-74.
1986: Torsteinsdottir S; Masucci M G; Brautbar C; Lenoir G; Klein G; Klein E
Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones.
Cellular immunology 1986;98(2):453-66.
1986: Saranath D; Masucci M G; Klein E
Cytotoxic factor produced by human blood lymphocytes of low density upon exposure to autologous B cells.
Immunology letters 1986;12(2-3):141-6.
1985: Bejarano M T; Masucci M G; Klein E
Specific and non-specific components in the triggering of proliferative and cytotoxic responses of T lymphocytes with different cell density.
Immunobiology 1985;170(3):175-91.
1985: Ramos O F; Masucci M G; Klein E
Modulation of human blood lymphocyte cytotoxicity by the phorbol ester tumor promoter P(Bu)2: increase of target binding, impairment of effector recycling, and activation of lytic potential which is independent of IL-2.
Cellular immunology 1985;91(1):178-92.
1985: Bejarano M T; Masucci M G; Ernberg I; Klein E; Klein G
Effect of cyclosporin-A (CsA) on the ability of T lymphocyte subsets to inhibit the proliferation of autologous EBV-transformed B cells.
International journal of cancer. Journal international du cancer 1985;35(3):327-33.
1985: Torsteinsdottir S; Masucci M G; Bejarano M T; Berthold W; Klein E; Klein G
Selective inhibitory effect of Hu-IFN-gamma on the agarose clonability of tumor-derived lymphoid cell lines.
Cellular immunology 1985;90(1):65-73.
1985: Szigeti R; Masucci M G; Masucci G; Aman P; Klein G; Klein E
Leukocyte migration inhibitory factor production by activated lymphocytes representing immunological memory or virus-receptor interaction: response of T cell subsets to Epstein-Barr virus nuclear antigen, response of B cells to UV inactivated Epstein-Barr virus.
Immunology letters 1985;9(5):267-73.
1984: Masucci M G; Torsteinsdottir S; Pear W; Carstensen A; Klein E
Phorbol esters inhibit the functional activation of cytotoxic precursors in mixed lymphocyte cultures.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(4):1755-62.
1984: Masucci G; Berkel I; Masucci M G; Ernberg I; Szigeti R; Ersoy F; Sanal O; Yegin O; Henle G; Henle W
Epstein-Barr virus (EBV)-specific cell-mediated and humoral immune responses in ataxia-telangectasia patients.
Journal of clinical immunology 1984;4(5):369-82.
1984: Torsteinsdottir S; Masucci M G; Szigeti R; Bishara A; Brautbar C; Klein G; Klein E
T lymphocyte culture established by repeated stimulation with the autologous lymphoblastoid line. MHC class II restricted interactions with B blasts.
Molecular biology & medicine 1984;2(4):285-99.
1984: Torsteinsdottir S; Masucci M G; Lenoir G; Klein G; Klein E
Natural killer cell sensitivity of human lymphoid lines of B-cell origin does not correlate with tumorigenicity or with the expression of certain differentiation markers.
Cellular immunology 1984;86(2):278-86.
1984: Masucci G; Szigeti R; Stevens D; Masucci M G; Klein E; Petersen J; Bendtzen K; Klein G
Production of leukocyte migration inhibitory factor (LIF) in human lymphocyte subsets exposed to polyclonal activators.
Cellular immunology 1984;85(2):511-8.
1984: Klein E; Vánky F; Masucci M G; Bejarano M T
Experimental and clinical data for the role of NK-cells in immunosurveillance.
Behring Institute Mitteilungen 1984;(74):140-8.
1984: Ramos O F; Masucci M G; Klein E
Activation of cytotoxic activity of human blood lymphocytes by tumor-promoting compounds.
Cancer research 1984;44(5):1857-62.
1984: Masucci G; Mellstedt H; Masucci M G; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Cancer research 1984;44(3):1288-300.
1984: Svedmyr E; Ernberg I; Seeley J; Weiland O; Masucci G; Tsukuda K; Szigeti R; Masucci M G; Blomogren H; Berthold W
Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis.
Clinical immunology and immunopathology 1984;30(3):437-50.
1984: Vánky F; Masucci M G; Bejarano M T; Klein E
Lysis of tumor biopsy cells by blood lymphocyte subsets of various densities. Autologous and allogeneic studies.
International journal of cancer. Journal international du cancer 1984;33(2):185-92.
1983: Ramos O F; Masucci M G; Bejarano M T; Klein E
The tumor promoter phorbol-12,13-dibutyrate [P(Bu)2] stimulates cytotoxic activity of human blood lymphocytes.
Immunobiology 1983;165(5):403-14.
1983: Masucci G; Masucci M G; Bejarano M T; Klein E
Comparison of highly NK active human lymphocyte subsets separated by various procedures involving E, EA rosetting, density gradients and adherence to immune complexes.
Journal of immunological methods 1983;63(1):57-67.
1983: Masucci M G; Klein E
Role of T cell subpopulations in the control of the proliferative potential of EBV transformed B cells.
Behring Institute Mitteilungen 1983;(72):163-8.
1983: Masucci M G; Bejarano M T; Masucci G; Klein E
Large granular lymphocytes inhibit the in vitro growth of autologous Epstein-Barr virus-infected B cells.
Cellular immunology 1983;76(2):311-21.
1982: Klein E; Masucci M G; Masucci G; Vánky F
Natural killer activity of human blood lymphocytes.
Molecular immunology 1982;19(10):1323-9.
1982: Masucci G; Masucci M G; Klein E
Human blood lymphocyte subsets separated on the basis of nylon adherence, SRBC and EA rosetting: natural cytotoxicity and characterization with monoclonal reagents.
Cellular immunology 1982;69(1):166-74.
1982: Szigeti R; Klein E; Masucci M G; Ernberg I; Masucci G; Svedmyr E; Klein G
[Leukocyte migration inhibition elicited by Epstein-Barr virus antigen. Reaction potential in infectious mononucleosis as well as in states of immune deficiency and immunosuppression]
Orvosi hetilap 1982;123(20):1217-21.
1982: Masucci G; Masucci M G; Klein E
Activation of human blood lymphocyte subsets for cytotoxic potential.
Cellular immunology 1982;69(1):21-33.
1982: Vánky F; Gorsky T; Gorsky Y; Masucci M G; Klein E
Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.
The Journal of experimental medicine 1982;155(1):83-95.
1982: Szigeti R; Masucci M G; Henle W; Henle G; Purtilo D; Klein G
Effect of different Epstein-Barr virus-determined antigens (EBNA, EA, and VCA) on the leukocyte migration of healthy donors and patients with infectious mononucleosis and certain immunodeficiencies.
Clinical immunology and immunopathology 1982;22(1):128-38.
1982: Wu Y; Ernberg I; Masucci M G; Johnson D; Klein E; Klein G
Human T cell growth factor (TCGF) produced by repeated stimulation of non-adherent human lymphocytes.
Journal of immunological methods 1982;51(1):35-44.
1982: Klein E; Masucci M G
Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.
Springer seminars in immunopathology 1982;5(1):63-73.
1981: Masucci M G; Szigeti R; Ernberg I; Björkholm M; Mellstedt H; Henle G; Henle W; Pearson G; Masucci G; Svedmyr E; Johansson B; Klein G
Cell-mediated immune reactions in three patients with malignant lymphoproliferative diseases in remission and abnormally high Epstein-Barr virus antibody titers.
Cancer research 1981;41(11 Pt 1):4292-301.
1981: Klein E; Ernberg I; Masucci M G; Szigeti R; Wu Y T; Masucci G; Svedmyr E
T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
Cancer research 1981;41(11 Pt 1):4210-5.
1981: Masucci M G; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo D T
Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
Cancer research 1981;41(11 Pt 1):4284-91.
1981: Szigeti R; Stevens D; Ernberg I; Klein G; Masucci M G; Svedmyr E; Klein E
Use of cryopreserved lymphocytes for the indirect leukocyte migration inhibition assay.
Journal of immunological methods 1981;46(3):369-74.
1980: Szigeti R; Masucci M G; Masucci G; Klein E; Klein G
Interferon suppresses antigen- and mitogen-induced leukocyte migration inhibition.
Nature 1980;288(5791):594-6.
1980: Masucci M G; Szigeti R; Klein E; Klein G; Gruest J; Montagnier L; Taira H; Hall A; Nagata S; Weissmann C
Effect of interferon-alpha 1 from E. coli on some cell functions.
Science (New York, N.Y.) 1980;209(4463):1431-5.
1980: Masucci M G; Masucci G; Klein E; Berthold W
Target selectivity of interferon-induced human killer lymphocytes related to their Fc receptor expression.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(6):3620-4.
1980: Masucci M G; Klein E; Argov S
Disappearance of the NK effect after explantation of lymphocytes and generation of similar nonspecific cytotoxicity correlated to the level of blastogenesis in activated cultures.
Journal of immunology (Baltimore, Md. : 1950) 1980;124(5):2458-63.

Sign-in to see more